3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Multiple Sclerosis
2
Small Cell Lung Carcinoma
1
Skin Neoplasms
1
Multiple Sclerosis, Relapsing-Remitting
1
Melanoma
1
Lymphopenia
1
Glioblastoma
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Basal Cell
1
Breast Neoplasms
1
Astrocytoma
1
Interventions
teriflunomide
1
Vitamin D
1
Natalizumab
1
Fingolimod Hydrochloride
1
Dimethyl Fumarate
1
Cholecalciferol
1
Calcifediol
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Multiple Sclerosis, Relapsing-Remitting
×
Fingolimod Hydrochloride
×
Clear all
NCT06705608
2024-11-26
MS; FTY720
University of British Columbia
Completed
4,000 enrolled